TRLHX
Price
$24.12
Change
+$0.16 (+0.67%)
Updated
Jul 3 closing price
Net Assets
6.59B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

TRLHX vs VVIAX

Header iconTRLHX vs VVIAX Comparison
Open Charts TRLHX vs VVIAXBanner chart's image
Nuveen Large Cap Value I
Price$24.12
Change+$0.16 (+0.67%)
VolumeN/A
Net Assets6.59B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
TRLHX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
TRLHX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRLHX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. TRLHX (6.59B). VVIAX pays higher dividends than TRLHX: VVIAX (2.18) vs TRLHX (1.27). TRLHX was incepted earlier than VVIAX: TRLHX (10 years) vs VVIAX (25 years). TRLHX (0.50) is less costly to investors than VVIAX (0.05). TRLHX is a more actively managed with annual turnover of: 19.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than TRLHX: VVIAX (3000) vs TRLHX (100000). TRLHX (12.13) and VVIAX (12.03) have marching annual gain over last year. VVIAX return over 5 years is better than : 80.13 vs. TRLHX (66.53).
TRLHXVVIAXTRLHX / VVIAX
Total Expense Ratio0.500.051,000%
Annual Report Gross Expense Ratio0.500.051,000%
Fund Existence10 years25 years-
Gain YTD9.3386.198151%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets6.59B189B3%
Annual Yield % from dividends1.272.1858%
Returns for 1 year12.1312.03101%
Returns for 3 years32.7435.1793%
Returns for 5 years66.5380.1383%
Returns for 10 yearsN/A115.67-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.